Physicochemical differences in the AH receptors of the most TCDD- susceptible and the most TCDD-resistant rat strains

Toxicology and Applied Pharmacology

Volumn 155, Issue 1, 1999, Pages 82-95

  Pohjanvirta, Raimo ^a,b   Viluksela, Matti ^a   Tuomisto, Jouni T ^a   Unkila, Mikko ^a   Karasinska, Joanna ^b   Franc, Monique Andrée ^b   Holowenko, Mary ^b   Giannone, John V ^b   Harper, Patricia A ^b,c   Tuomisto, Jouko ^a   Okey, Allan B ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; MOLYBDIC ACID; SODIUM CHLORIDE; TUNGSTEN DERIVATIVE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOSENSITIVITY; CONTROLLED STUDY; DNA BINDING; LETHALITY; LIGAND BINDING; MALE; MOLECULAR WEIGHT; NONHUMAN; PROTEIN ANALYSIS; RAT; RECEPTOR BINDING; STRAIN DIFFERENCE;

ANIMALIA; RATTUS NORVEGICUS; RODENTIA;

EID: 0033037797     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8565     Document Type: Article

References (73)

1. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
2. r. Biochemistry. 29:1990;520-527.
3. Brewster D. W., Birnbaum L. S. The biochemical toxicity of perfluorodecanoic acid in the mouse is different from that of 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 99:1989;544-554.
4. Carlstedt-Duke J. M. B. Tissue distribution of the receptor for 2,3,7,8-tetrachlorodibenzo-p. Cancer Res. 39:1979;3172-3176.
5. Carver L. A., Hogenesch J. B., Bradfield C. A. Tissue specific expression of the rat Ah-receptor and ARNT mRNAs. Nucleic Acids Res. 22:1994;3038-3044.
6. Chang C., Smith D. R., Prasad V. S., Sidman C. L., Nebert D. W., Puga A. Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. Pharmacogenetics. 3:1993;312-321.
7. Chapman D. E., Schiller C. M. Dose-related effects of 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 78:1985;147-157.
8. Dahmer M. K., Housley P. R., Pratt W. B. Effects of molybdate and endogenous inhibitors on steroid-receptor inactivation, transformation, and translocation. Annu. Rev. Physiol. 46:1984;67-81.
9. Denison M. S., Vella L. M. The hepatic Ah receptor for 2,3,7,8-tetrachlorodibenzo-p. Arch. Biochem. Biophys. 277:1990;382-388.
10. Denison M. S., Vella L. M., Okey A. B. Structure and function of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p. J. Biol. Chem. 261:1986a;3987-3995.
11. Denison M. S., Vella L. M., Okey A. B. HepaticAhp. J. Biol. Chem. 261:1986b;10189-10195.
12. Denison M. S., Yao E. F. Characterization of the interaction of transformed rat hepatic cytosolic Ah receptor with a dioxin responsive transcriptional enhancer. Arch. Biochem. Biophys. 284:1991;158-166.
13. Dolwick K. M., Schmidt J. V., Carver L. A., Swanson H. I., Bradfield C. A. Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol. 44:1993;911-917.
14. Drutel G., Kathmann M., Heron A., Schwartz J.-C., Arrang J.-M. Cloning and selective expression in brain and kidney of ARNT2 homologous to the Ah receptor nuclear translocator (ARNT). Biochem. Biophys. Res. Commun. 225:1996;333-339.
15. Elferink C. J., Whitlock J. P. Jr. Dioxin-dependent, DNA sequence-specific binding of a multiprotein complex containing the Ah receptor. Receptor. 4:1994;157-173.
16. Ema M., Ohe N., Suzuki M., Mimura J., Sogawa K., Ikawa S., Fujii-Kuriyama Y. Dioxin binding activities of polymorphic forms of mouse and human aryl-hydrocarbon receptors. J. Biol. Chem. 269:1994;27337-27343.
17. Giannone J. V., Okey A. B., Harper P. A. Characterization of polyclonal antibodies to the aromatic hydrocarbon receptor. Can. J. Physiol. Pharmacol. 73:1995;7-17.
18. Greig J. B., Francis J. E., Kay S. J. E., Lovell D. P., Smith A. G. Incomplete correlation of 2,3,7,8-tetrachlorodibenzo-pAh. Toxicol. Appl. Pharmacol. 74:1984;17-25.
19. Greim H., Rozman K. Mechanism(s) of toxicity of 2,3,7,8-tetrachlorodibenzo-p. VDI-Ber. 634:1987;399-429.
20. Hahn M. E., Poland A., Glover E., Stegeman J. J. Photoaffinity labeling of the Ah receptor: Phylogenetic survey of diverse vertebrate and invertebrate species. Arch. Biochem. Biophys. 310:1994;218-228.
21. Hankinson O. Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT). Mol. Cell. Biol. 14:1994;6075-6086.
22. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35:1995;307-340.
23. Harper P. A., Giannone J. V., Okey A. B., Denison M. S. In vitro. Mol. Pharmacol. 42:1992;603-612.
24. Harper P. A., Prokipcak R. D., Bush L. E., Golas C. E., Okey A. B. Detection and characterization of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p. Arch. Biochem. Biophys. 290:1991;27-36.
25. Harris M. W., Uraih L. C., Birnbaum L. S. Acute toxicity of perfluorodecanoic acid in C57BL/6 mice differs from 2,3,7,8-tetrachlorodibenzo-p. Fundam. Appl. Pharmacol. 13:1989;723-736.
26. Hoffman E. C., Reyes H., Chu F. F., Sander F., Conley L. H., Brooks B. A., Hankinson O. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science (Washington, D.C.). 252:1991;954-958.
27. Hogenesch J. B., Chan W. K., Jackiw V. H., Brown R. C., Gu Y.-Z., Pray-Grant M., Perdew G. H., Bradfield C. A. Characterization of a subset of the basic helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway. J. Biol. Chem. 272:1997;8581-8593.
28. Holmes J. L., Pollenz R. S. Determination of aryl hydrocarbon receptor nuclear translocator protein concentration and subcellular localization in hepatic and nonhepatic cell culture lines - Development of quantitative Western blotting protocols for calculation of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein in total cell lysates. Mol. Pharmacol. 52:1997;202-211.
29. Huuskonen H., Unkila M., Pohjanvirta R., Tuomisto J. Developmental toxicity of 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 124:1994;174-180.
30. Jain S., Dolwick K. M., Schmidt J. V., Bradfield C. A. Potent transactivation domains of the Ah receptor and the Ah receptor nuclear translocator map to their carboxyl termini. J. Biol. Chem. 269:1994;31518-31524.
31. Knutson J. C., Poland A. Response of murine epidermis to 2,3,7,8-tetrachlorodibenzo-pAhhr. Cell. 30:1982;225-234.
32. Lin F. H., Clark G., Birnbaum L. S., Lucier G. W., Goldstein J. A. Influence of theAhp. Mol. Pharmacol. 39:1991;307-317.
33. Linden J., Pohjanvirta R., Rahko T., Tuomisto J. TCDD decreases rapidly and persistently serum melatonin concentration without morphologically affecting the pineal gland in TCDD-resistant Han/Wistar rats. Pharmacol. Toxicol. 69:1991;427-432.
34. Manchester D. K., Gordon S. K., Golas C. L., Roberts E. A., Okey A. B. Ahpa. Cancer Res. 47:1987;4861-4868.
35. Mason M. E., Okey A. B. Cytosolic and nuclear binding of 2,3,7,8-tetrachlorodibenzo-pAh. Eur. J. Biochem. 123:1982;209-215.
36. Meshinchi S., Stancato L. F., Gordon B. M., Jones K. W., Pratt W. B. Purification of the endogenous glucocorticoid receptor stabilizing factor. Biochemistry. 30:1991;8617-8622.
37. Modarress K. J., Cavanaugh A. H., Chakraborti P. K., Simons S. S. Jr. Metal oxyanion stabilization of the rat glucocorticoid receptor is independent of thiols. J. Biol. Chem. 269:1994;25621-25628.
38. 3. J. Biol. Chem. 269:1994;12129-12136.
39. Okey A. B., Riddick D. S., Harper P. A. The Ah receptor: Mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Lett. 70:1994;1-22.
40. 1. Mol. Pharmacol. 35:1989;823-830.
41. Perdew G. H. Association of theAh. J. Biol. Chem. 263:1988;13802-13805.
42. Perdew G. H., Bradfield C. A. Mapping the 90 kDa heat shock protein binding region of the Ah receptor. Biochem. Mol. Biol. Int. 39:1996;589-593.
43. Pohjanvirta R. TCDD resistance is inherited as an autosomal dominant trait in the rat. Toxicol. Lett. 50:1990;49-56.
44. Pohjanvirta R., Håkansson H., Juvonen R., Tuomisto J. Effects of TCDD on vitamin A status and liver microsomal enzyme activities in a TCDD-susceptible and a TCDD-resistant rat strain. Food Chem. Toxicol. 28:1990;197-203.
45. Pohjanvirta R., Juvonen R., Kärenlampi S., Raunio H., Tuomisto J. Hepatic Ah-receptor levels and the effect of 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 92:1988;131-140.
46. Pohjanvirta R., Tuomisto J. Letter to the editor (about rat strain differences to TCDD). Toxicol. Appl. Pharmacol. 105:1990;508-509.
47. Pohjanvirta R., Tuomisto J. Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p. Pharmacol. Rev. 46:1994;483-549.
48. Pohjanvirta R., Tuomisto L., Tuomisto J. The central nervous system may be involved in TCDD toxicity. Toxicology. 58:1989;167-174.
49. Pohjanvirta R., Unkila M., Lindèn J., Tuomisto J. T., Tuomisto J. Toxic equivalency factors do not predict the acute toxicities of dioxins in rats. Eur. J. Pharmacol., Environ. Toxicol. Pharmacol. 293:1995;341-353.
50. Pohjanvirta R., Unkila M., Tuomisto J. Comparative acute lethality of 2,3,7,8-tetrachlorodibenzo-ppp. Pharmacol. Toxicol. 73:1993;52-56.
51. Pohjanvirta R., Wong J. M. Y., Li W., Harper P. A., Tuomisto J., Okey A. B. Point mutation in intron sequence causes altered carboxyl-terminal structure in the aryl hydrocarbon receptor of the most 2, 3, 7, 8-tetrachlorodibenzo-p. Mol. Parmacol. 54:1998;86-93.
52. Poland A., Glover E. 2,3,7,8-Tetrachlorodibenzo-pAh. Mol. Pharmacol. 17:1980;86-94.
53. Poland A., Glover E. Variation in the molecular mass of the Ah receptor among vertebrate species and strains of rats. Biochem. Biophys. Res. Commun. 146:1987;1439-1449.
54. Poland A., Palen D., Glover E. Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol. Pharmacol. 46:1994;915-921.
55. Pollenz R. S., Sattler C. A., Poland A. The aryl hydrocarbon receptor and aryl hydrocarbon nuclear translocator protein show distinct subcellular localizations in Hepa lclc7 cells by immunofluoresence microscopy. Mol. Pharmacol. 45:1994;428-438.
56. Pongratz I., Mason G. G. F., Poellinger L. Dual roles of the 90-kDa heat shock protein hsp90 in modulating functional activities of the dioxin receptor. J. Biol. Chem. 267:1992;13728-13734.
57. Probst M. R., Fan C.-M., Tessier-Lavigne M., Hankinson O. Two murine homologs of theDrosophila. J. Biol. Chem. 272:1997;4451-4457.
58. Prokipcak R. D., Okey A. B. Equivalent molecular mass of cytosolic and nuclear forms of Ah receptor from Hepa-1 cells determined by photoaffinity labeling with 2,3,7,8-tetrachlorodibenzo-p. Biochem. Biophys. Res. Commun. 172:1990;698-704.
59. Rowlands J. C., McEwan I. J., Gustafsson J.-Å. Trans. Mol. Pharmacol. 50:1996;538-548.
60. Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p. Crit. Rev. Toxicol. 21:1990;51-88.
61. Swanson H. I., Bradfield C. A. The AH-receptor: Genetics, structure and function. Pharmacogenetics. 3:1993;213-230.
62. 125p. Toxicol. Lett. 58:1991;85-95.
63. Tsui H. W., Okey A. B. Rapid vertical tube rotor gradient assay for binding of 2,3,7,8-tetrachlorodibenzo-pAh. Can. J. Physiol. Pharmacol. 59:1981;927-931.
64. Tuomisto J., Sewall C. H., Unkila M., Pohjanvirta R., Clark C. G., Viluksela M., Rozman K., Lucier G. W. Differences in binding of epidermal growth factor to liver membranes of TCDD-resistant and TCDD-sensitive rats after a single dose of TCDD. Environ. Toxicol. Pharmacol. 1:1996;109-116.
65. Tuomisto J. T., Viluksela M., Pohjanvirta R., Tuomisto J. The AH receptor and a novel gene determine acute toxic responses to TCDD: Segregation of the resistant alleles to different rat lines. Toxicol. Appl. Pharmacol. 154:1999;71-81.
66. 3. Biochem. Pharmacol. 46:1993;651-659.
67. Unkila M., Pohjanvirta R., MacDonald E., Tuomisto J. T., Tuomisto J. Dose-response and time course of alterations in tryptophan metabolism by 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 128:1994;280-293.
68. Unkila M., Pohjanvirta R., Tuomisto J. Acute toxicity of perfluorodecanoic acid and cobalt protoporphyrin in a TCDD-sensitive and a TCDD-resistant rat strain. Chemosphere. 25:1992;1233-1239.
69. Vartiainen T., Lampi P., Tolonen K., Tuomisto J. Polychlorodibenzo-p. Chemosphere. 30:1995;1439-1446.
70. 2. Proc. Natl. Acad. Sci. USA. 92:1995;5510-5514.
71. Wheeler R. H., Leach K. L., La Forest A. C., O'Toole T. E., Wagner R., Pratt W. B. Glucocorticoid-receptor activation and inactivation in cultured human lymphocytes. J. Biol. Chem. 256:1981;434-441.
72. Whitelaw M. L., Gustafsson J.-Å., Poellinger L. Identification oftrans. Mol. Cell. Biol. 14:1994;8343-8355.
73. Whitlock J. P. Jr. Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p. Annu. Rev. Pharmacol. Toxicol. 30:1990;251-277.